Sandra Bos

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Advanced Non Small Cell Lung Cancer

Top Venues

medRxiv : the preprint server for health sciences

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Bos, José Victor Zambrana, Elias M Duarte, Aaron L Graber, Julia Huffaker, Carlos Montenegro, Lakshmanane Premkumar, Aubree Gordon, Angel Balmaseda, Eva Harris
Serotype-Specific Epidemiological Patterns of Inapparent versus Symptomatic Primary Dengue Virus Infections: A 17-year cohort study in Nicaragua. medRxiv : the preprint server for health sciences (2024)
José Victor Zambrana, Chloe M Hasund, Rosemary A Aogo, Sandra Bos, Sonia Arguello, Karla Gonzalez, Damaris Collado, Tatiana Miranda, Guillermina Kuan, Aubree Gordon, Angel Balmaseda, Leah C Katzelnick, Eva Harris
Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Science translational medicine 16 (749) (2024)
Sandra Bos, José Victor Zambrana, Elias Duarte, Aaron L Graber, Julia Huffaker, Carlos Montenegro, Lakshmanane Premkumar, Aubree Gordon, Angel Balmaseda, Eva Harris
Inapparent primary dengue virus infections reveal hidden serotype-specific epidemiological patterns and spectrum of infection outcome: a cohort study in Nicaragua. medRxiv : the preprint server for health sciences (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, José Victor Zambrana, Elias Duarte, Aaron L Graber, Julia Huffaker, Carlos Montenegro, Lakshmanane Premkumar, Aubree Gordon, Angel Balmaseda, Eva Harris
Inapparent primary dengue virus infections reveal hidden serotype-specific epidemiological patterns and spectrum of infection outcome: a cohort study in Nicaragua. medRxiv : the preprint server for health sciences (2024)
Antonio G Dias, Elias Duarte, Jose Victor Zambrana, Jaime A Cardona-Ospina, Sandra Bos, Vicky Roy, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris
Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease. medRxiv : the preprint server for health sciences (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Antonio G Dias, Elias Duarte, Jose Victor Zambrana, Jaime A Cardona-Ospina, Sandra Bos, Vicky Roy, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris
Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease. medRxiv : the preprint server for health sciences (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
José Victor Zambrana, Chloe M Hasund, Rosemary A Aogo, Sandra Bos, Sonia Arguello, Karla Gonzalez, Damaris Collado, Tatiana Miranda, Guillermina Kuan, Aubree Gordon, Angel Balmaseda, Leah C Katzelnick, Eva Harris
Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Science translational medicine 16 (749) (2024)
Antonio G Dias, Elias Duarte, Jose Victor Zambrana, Jaime A Cardona-Ospina, Sandra Bos, Vicky Roy, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris
Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease. medRxiv : the preprint server for health sciences (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron Graber, Jaime A Cardona-Ospina, Elias Duarte, José Victor Zambrana, Jorge Alberto Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah Katzelnick, Aravinda de Silva, Guillermina Kuan, Angel Balmaseda, Eva Harris
The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior immunity, and assay condition. medRxiv : the preprint server for health sciences (2023)
José Victor Zambrana, Chloe M Hasund, Rosemary A Aogo, Sandra Bos, Sonia Arguello, Karla Gonzalez, Damaris Collado, Tatiana Miranda, Guillermina Kuan, Aubree Gordon, Angel Balmaseda, Leah C Katzelnick, Eva Harris
Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1. medRxiv : the preprint server for health sciences (2023)
Antonio G Dias, Caroline G Atyeo, Carolin Loos, Magelda Montoya, Vicky Roy, Sandra Bos, Parnal Narvekar, Tulika Singh, Leah C Katzelnick, Guillermina Kuan, Douglas A Lauffenburger, Angel Balmaseda, Galit Alter, Eva Harris
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection. Science translational medicine 14 (651) (2022)
Ge Li, Sandra Bos, Konstantin A Tsetsarkin, Alexander G Pletnev, Philippe Desprès, Gilles Gadea, Richard Y Zhao
The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity. Viruses 11 (2) (2019)
Sandra Bos, Wildriss Viranaïcken, Étienne Frumence, Ge Li, Philippe Desprès, Richard Y Zhao, Gilles Gadea
The Envelope Residues E152/156/158 of Zika Virus Influence the Early Stages of Virus Infection in Human Cells. Cells 8 (11) (2019)
Étienne Frumence, Wildriss Viranaïcken, Sandra Bos, Maria-Teresa Alvarez-Martinez, Marjolaine Roche, Jacques-Damien Arnaud, Gilles Gadea, Philippe Desprès
A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization. Vaccines 7 (2) (2019)
Chaker El Kalamouni, Etienne Frumence, Sandra Bos, Jonathan Turpin, Brice Nativel, Wissal Harrabi, David A Wilkinson, Olivier Meilhac, Gilles Gadea, Philippe Desprès, Pascale Krejbich-Trotot, Wildriss Viranaïcken
Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus. Viruses 11 (1) (2018)
Arnaud Gaudry, Sandra Bos, Wildriss Viranaicken, Marjolaine Roche, Pascale Krejbich-Trotot, Gilles Gadea, Philippe Desprès, Chaker El Kalamouni
The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells. International journal of molecular sciences 19 (4) (2018)
Sandra Bos, Gilles Gadea, Philippe Desprès
Dengue: a growing threat requiring vaccine development for disease prevention. Pathogens and global health 112 (6) (2018)
Ina Lee, Sandra Bos, Ge Li, Shusheng Wang, Gilles Gadea, Philippe Desprès, Richard Y Zhao
Probing Molecular Insights into Zika Virus⁻Host Interactions. Viruses 10 (5) (2018)
Wildriss Viranaicken, Alexia Ndebo, Sandra Bos, Philippe Souque, Gilles Gadea, Chaker El-Kalamouni, Pascale Krejbich-Trotot, Pierre Charneau, Philippe Desprès, Marjolaine Roche
Recombinant Zika NS1 Protein Secreted from Vero Cells Is Efficient for Inducing Production of Immune Serum Directed against NS1 Dimer. International journal of molecular sciences 19 (1) (2017)